Abstract:Compared to the conventional anti-cancer drugs, the nano-drug delivery systems (NDDS) shows a comparatively ideal therapeutic efficacy ascribing their high tumor-target capacity and efficient drug release ability. In this study, a novel macromolecular prodrug conjugate was designed and developed that is passively triggered by the acidic environment of the tumor cells and can release doxorubicin (Dox). The susceptibility of the system to the acidic environment is due to the acid volatile Schiff base covalent bond between grafted carboxymethyl chitosan (CMCs) and Dox. The chemical structure of the finalized system was characterized by 1H-NMR spectroscopy. Because of the hydrophobicity of the Dox and the hydrophilicity of the CMCs, the amphipathic polymeric drug conjugates can self-assemble into the nanoparticles in aqueous solution. The morphology and size of the nanoparticles were observed with TEM (transmission electron microscopy) and DLS (dynamic light scattering). The in vitro drug release studies demonstrated that the drug release rate of the prodrug were visibly higher in acidic conditions (pH 5.0) compared to higher pHs like 6.5 and 7.4. DLS results showed that the mean size of the prodrug nanoparticles increased as the pH of the solution decreased from 7.4 to 6.5 and 5.0. Furthermore, the cell counting kit-8 (CCK-8) assays showed that the polymeric drug nanoparticles had a cytotoxic effect on SKOV3 ovarian cancer cells while the segments of the DDS revealed comparatively lower cytotoxic effect. Moreover, confocal laser scanning microscopy (CLSM) showed that the prodrug could efficiently deliver and release Dox in the nuclei of the cancer cells while this was not observed for the Dox pure drug. These results proved that the carboxymethyl chitosan-CBA-Doxorubicin NPs have superior stabilities, low toxicities, proper sizes, and enhanced curable efficiency for in vitro controlled release. Thus, this pH-sensitive prodrug could be a potential treatment for cancer therapy in the near future.

Investigation of Polymeric Amphiphilic Nanoparticles As Antitumor Drug Carriers

Self-assembled Nanoparticles Based on Hydrophobically Modified Chitosan As Carriers for Doxorubicin.

Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.

Effect of Molecular Weight on the Oleoyl-Chitosan Nanoparticles As Carriers for Doxorubicin.

Ph-Sensitive Chitosan-Derived Nanoparticles As Doxorubicin Carriers for Effective Anti-Tumor Activity: Preparation and in Vitro Evaluation.

Self-assembled Amphiphilic Copolymers–doxorubicin Conjugated Nanoparticles for Gastric Cancer Therapy with Low in Vivo Toxicity and High Efficacy

Preparation and Research on the Anti-Tumor Activity of Doxorubicin Loaded High Polymer Micelles

Chitosan functionalized doxorubicin loaded poly(methacrylamide) based copolymeric nanoparticles for enhanced cellular internalization and in vitro anticancer evaluation

Synthesis and characterization of low-toxic amphiphilic chitosan derivatives and their application as micelle carrier for antitumor drug.

Construction of Amphiphilic Copolymer Nanoparticles Based on Hyperbranched Poly (Amine-Ester) and 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine As Drug Carriers for Cancer Therapy.

In vitro evaluation of anticancer nanomedicines based on doxorubicin and amphiphilic Y-shaped copolymers.

Potential of amphiphilically modified low molecular weight chitosan as a novel carrier for hydrophobic anticancer drug: Synthesis, characterization, micellization and cytotoxicity evaluation

Synthesis and characterization of amphiphilic glycidol-chitosan-deoxycholic acid nanoparticles as a drug carrier for doxorubicin.

Construction of amphiphilic copolymer nanoparticles based on gelatin as drug carriers for doxorubicin delivery.

In Vitro Evaluation of Polymeric Micelles Based on Hydrophobically-Modified Sulfated Chitosan As a Carrier of Doxorubicin

Novel Amphiphilic Dextran Copolymers Nanoparticles for Delivery of Doxorubicin

Hybrid Nanoparticles Based on Ortho Ester-Modified Pluronic L61 and Chitosan for Efficient Doxorubicin Delivery

Synthesis and in Vitro Characterization of Carboxymethyl Chitosan-CBA-Doxorubicin Conjugate Nanoparticles As Ph-Sensitive Drug Delivery Systems

Synthesis and Evaluation of Ph-Sensitive, Self-Assembled Chitosan-Based Nanoparticles As Efficient Doxorubicin Carriers

Amphiphilically modified chitosan cationic nanoparticles for drug delivery

Effect of Polymer Side Chains on Drug Delivery Properties for Cancer Therapy.